In women with Lynch syndrome (LS) carrying pathogenic constitutional variants in the DNA mismatch repair (MMR) genes MLH1, MSH2, or MSH6, the lifetime risks are significantly higher, and the mutated gene greatly affects cancer susceptibility.2 This evidence concerns the gene MSH2 and cancer.